| Announce Date | 01/27/2026 |
| EPS Normalized Actual | $1.93 (Beat by $0.14) |
| EPS GAAP Actual | $1.93 (Beat by $0.14) |
| Revenue Actual | $1.42148B |
| Revenue Surprise | Beat by $1421.48M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.95 |
| EPS GAAP Estimate | $0.95 |
| Revenue Estimate | $1.0519B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Mar 2030 | 8.7 | 10.51 | 8.53249 | 8.88486 | 2 |
| Mar 2029 | 7.87 | 11.62 | 7.71847 | 8.03722 | 4 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 1.71 | 0.57 | 1.42148B | 5.71% | 247.38M |
| FQ3 2025 (Sep 2025) | 1.16 | -0.04 | 1.18606B | 6.46% | 3.06M |
| FQ2 2025 (Jun 2025) | 0.99 | 0.99 | 1.1477B | 5.18% | 1147.7M |
| FQ1 2025 (Mar 2025) | 0.97 | 0.97 | 1.01036B | 2.97% | 1010.36M |
| FQ4 2024 (Dec 2024) | 1.33 | 1.33 | 1.34029B | 6.33% | 1340.29M |
| FQ3 2024 (Sep 2024) | 0.95 | 0.95 | 1.10944B | 4.73% | 1109.44M |
| FQ2 2024 (Jun 2024) | 0.93 | 0.93 | 1.08822B | 10.45% | 1088.22M |
| FQ1 2024 (Mar 2024) | 1.05 | 1.05 | 0.980352B | 2.07% | 980.35M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.95
Consensus Revenue Estimates
1.0519B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Mar 2028) | 1.36 | -- | 1.31312 | 1.39895 | 3 |
| FQ4 2027 (Dec 2027) | 1.79 | -- | 1.7283 | 1.84127 | 2 |
| FQ3 2027 (Sep 2027) | 1.4477 | -- | 1.16912 | 1.51055 | 1 |
| FQ2 2027 (Jun 2027) | 1.392 | -- | 1.12414 | 1.45243 | 1 |
| FQ1 2027 (Mar 2027) | 1.09 | -- | 1.06729 | 1.12152 | 2 |
| FQ4 2026 (Oct 2026) | 1.2099 | -41.33 | 1.1521 | 1.24743 | 3 |
| FQ3 2026 (Jul 2026) | 1.0963 | -5.81 | 1.04392 | 1.13031 | 3 |
| FQ2 2026 (Jun 2026) | 1.0963 | 9.7 | 1.05225 | 1.12725 | 1 |
| FQ1 2026 (Mar 2026) | 0.95 | -2.11 | 0.8913 | 0.98511 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Mar 2028) | 1.18B | -- | 1.15B | 1.21B | 3 |
| FQ4 2027 (Dec 2027) | 1.51B | -- | 1.47B | 1.54B | 6 |
| FQ3 2027 (Sep 2027) | 1.3B | -- | 1.11B | 1.34B | 3 |
| FQ2 2027 (Jun 2027) | 1.25B | -- | 1.07B | 1.29B | 3 |
| FQ1 2027 (Mar 2027) | 1.14B | -- | 1.12B | 1.17B | 4 |
| FQ4 2026 (Oct 2026) | 1.25B | -13.49 | 1.21B | 1.28B | 2 |
| FQ3 2026 (Jul 2026) | 1.2B | 1.2 | 1.16B | 1.23B | 2 |
| FQ2 2026 (Jun 2026) | 1.2B | 4.4 | 1.16B | 1.23B | 2 |
| FQ1 2026 (Mar 2026) | 1.05B | 3.95 | 1B | 1.08B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 1.14 | 1.71 | 0.57 | 33.33% |
| FQ3 2025 (Sep 2025) | 1.2 | 1.16 | -0.04 | -3.45% |
| FQ2 2025 (Jun 2025) | 0.99 | 0.99 | 100% | |
| FQ1 2025 (Mar 2025) | 0.97 | 0.97 | 100% | |
| FQ4 2024 (Dec 2024) | 1.33 | 1.33 | 100% | |
| FQ3 2024 (Sep 2024) | 0.95 | 0.95 | 100% | |
| FQ2 2024 (Jun 2024) | 0.93 | 0.93 | 100% | |
| FQ1 2024 (Mar 2024) | 1.05 | 1.05 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $1.17B | $1.42B | $247.38M | 17.4% |
| FQ3 2025 (Sep 2025) | $1.18B | $1.19B | $3.06M | 0.26% |
| FQ2 2025 (Jun 2025) | $0B | $1.15B | $1147.7M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1.01B | $1010.36M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.34B | $1340.29M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.11B | $1109.44M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.09B | $1088.22M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.98B | $980.35M | 100% |